(Q50532806)

14 March 2018

title

[Improvement in fibrinolytic function following anticoagulant treatment in chronic rheumatic atrial fibrillation] (English)

1 reference

14 March 2018

0 references

1 reference

1 reference

Marín Ortuño F

1

1 reference

14 March 2018

Roldán Schilling V

2

1 reference

14 March 2018

Marco Vera P

3

1 reference

14 March 2018

Martínez Martínez JG

4

1 reference

14 March 2018

Toral Noguera A

5

1 reference

14 March 2018

García de Burgos Rico F

6

1 reference

14 March 2018

Calatayud Sendra R

7

1 reference

14 March 2018

Sogorb Garri F

8

1 reference

14 March 2018

publication date

1 January 1999

1 reference

14 March 2018

Revista Española de Cardiología

published in

1 reference

14 March 2018

volume

52

1 reference

14 March 2018

issue

1

1 reference

14 March 2018

page(s)

25-30

1 reference

14 March 2018

Antithrombotic therapy in atrial fibrillation

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2899%2974861-X

7 January 2021

Coagulation activity is increased in the left atrium of patients with mitral stenosis

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2899%2974861-X

7 January 2021

Epidemiologic assessment of chronic atrial fibrillation and risk of stroke: The fiamingham Study

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2899%2974861-X

7 January 2021

Activation of the coagulation system in women with mitral stenosis and sinus rhythm

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2899%2974861-X

7 January 2021

Guide to anticoagulant therapy. Part 1: Heparin. American Heart Association

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2899%2974861-X

7 January 2021

Does atrial fibrillation confer a hypercoagulable state?

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2899%2974861-X

7 January 2021

Increased intracardiovascular clotting in patients with chronic atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2899%2974861-X

7 January 2021

Increased markers of thrombogenesis in chronic atrial fibrillation: effects of warfarin treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2899%2974861-X

7 January 2021

Effects of aspirin on status of thrombin generation in atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2899%2974861-X

7 January 2021

Intracardiac mobile thrombus and D-dimer fragment of fibrin in patients with mitral stenosis

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2899%2974861-X

7 January 2021

Effect of low-intensity warfarin anticoagulation on level of activity of the hemostatic system in patients with atrial fibrillation. BAATAF Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2899%2974861-X

7 January 2021

Effect of warfarin on regional left atrial coagulation activity in mitral stenosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2899%2974861-X

7 January 2021

Fibrin D-dimer and beta-thromboglobulin as markers of thrombogenesis and platelet activation in atrial fibrillation. Effects of introducing ultra-low-dose warfarin and aspirin

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2899%2974861-X

7 January 2021

Fibrinogen and fibrin D-dimer levels in paroxysmal atrial fibrillation: evidence for intermediate elevated levels of intravascular thrombogenesis.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2899%2974861-X

7 January 2021

Tissue plasminogen activator and plasminogen activator inhibitor-1 in stroke patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2899%2974861-X

7 January 2021

Prospective study of endogenous tissue plasminogen activator and risk of stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2899%2974861-X

7 January 2021

Fibrinolytic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. ECAT Study Group. European Concerted Action on Thrombosis and Disabilities

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2899%2974861-X

7 January 2021

10.1016/S0300-8932(99)74861-X

Identifiers

DOI

1 reference

14 March 2018

1 reference

14 March 2018